Literature DB >> 14678352

Paediatric methylphenidate (Ritalin) restrictive conditions of prescription in France.

C Frances, G Hoizey, H Millart, T Trenque.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14678352      PMCID： PMC1884413          DOI： 10.1046/j.1365-2125.2003.01943.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use.

Authors:  C Poulin
Journal:  CMAJ       Date:  2001-10-16       Impact factor: 8.262

2.  Intranasal abuse of prescribed methylphenidate.

Authors:  E J Garland
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1998-06       Impact factor: 8.829

Review 3.  Personal paper: attention deficit hyperactivity disorder is underdiagnosed and undertreated in Britain.

Authors:  G D Kewley
Journal:  BMJ       Date:  1998-05-23

4.  Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings.

Authors:  R T Brown; W S Freeman; J M Perrin; M T Stein; R W Amler; H M Feldman; K Pierce; M L Wolraich
Journal:  Pediatrics       Date:  2001-03       Impact factor: 7.124

5.  Stimulant treatment in Maryland public schools.

Authors:  D J Safer; M Malever
Journal:  Pediatrics       Date:  2000-09       Impact factor: 7.124

6.  Trends in the prescribing of psychotropic medications to preschoolers.

Authors:  J M Zito; D J Safer; S dosReis; J F Gardner; M Boles; F Lynch
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

7.  Increased methylphenidate usage for attention deficit disorder in the 1990s.

Authors:  D J Safer; J M Zito; E M Fine
Journal:  Pediatrics       Date:  1996-12       Impact factor: 7.124
  7 in total
  7 in total

1.  Detection of signals of abuse and dependence applying disproportionality analysis.

Authors:  V Pauly; M Lapeyre-Mestre; D Braunstein; M Rueter; X Thirion; E Jouanjus; J Micallef
Journal:  Eur J Clin Pharmacol       Date:  2014-11-20       Impact factor: 2.953

2.  Patterns and profiles of methylphenidate use both in children and adults.

Authors:  Vanessa Pauly; Elisabeth Frauger; Magalie Lepelley; Michel Mallaret; Quentin Boucherie; Joëlle Micallef
Journal:  Br J Clin Pharmacol       Date:  2018-04-16       Impact factor: 4.335

3.  Patterns of methylphenidate use and assessment of its abuse and diversion in two French administrative areas using a proxy of deviant behaviour determined from a reimbursement database: main trends from 2005 to 2008.

Authors:  Elisabeth Frauger; Vanessa Pauly; François Natali; Vincent Pradel; Patrick Reggio; Hervé Coudert; Xavier Thirion; Joëlle Micallef
Journal:  CNS Drugs       Date:  2011-05       Impact factor: 5.749

4.  Prevalence and patterns of methylphenidate use in French children and adolescents.

Authors:  Anne-Laure Knellwolf; Jean Deligne; Flavia Chiarotti; Guy-Robert Auleley; Serena Palmieri; Claudine Blum Boisgard; Pietro Panei; Elisabeth Autret-Leca
Journal:  Eur J Clin Pharmacol       Date:  2007-11-20       Impact factor: 2.953

5.  Hair loss due to methylphenidate use: A case study.

Authors:  Öznur Bilaç; Meryem Özlem Kütük; Cemal Bilaç
Journal:  Indian J Psychiatry       Date:  2018 Jan-Mar       Impact factor: 1.759

6.  A three-country comparison of psychotropic medication prevalence in youth.

Authors:  Julie M Zito; Daniel J Safer; Lolkje T W de Jong-van den Berg; Katrin Janhsen; Joerg M Fegert; James F Gardner; Gerd Glaeske; Satish C Valluri
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2008-09-25       Impact factor: 3.033

7.  The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial.

Authors:  Laurence Lion-François; François Gueyffier; Catherine Mercier; Daniel Gérard; Vania Herbillon; Isabelle Kemlin; Diana Rodriguez; Tiphanie Ginhoux; Emeline Peyric; Virginie Coutinho; Valentine Bréant; Vincent des Portes; Stéphane Pinson; Patrick Combemale; Behrouz Kassaï
Journal:  Orphanet J Rare Dis       Date:  2014-09-10       Impact factor: 4.123
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.